Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.

Abstract

The cytokine soluble CD23 (sCD23) has been shown to act as a B cell growth factor and to be elevated in serum prior to development of AIDS-related non-Hodgkin's lymphoma (AIDS NHL). To further characterize the elevation of serum sCD23 in AIDS NHL patients and investigate its potential as a diagnostic test, a matched case-control study of AIDS NHL (n = 101… (More)

Topics

6 Figures and Tables

Cite this paper

@article{Schroeder1999SerumSC, title={Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.}, author={Jennifer R. Schroeder and Alfred J. Saah and Dr Robert N. Hoover and Joseph B. Margolick and Richard Frederick Ambinder and Otoniel Mart{\'i}nez-Maza and E C Breen and Lisa Paula Jacobson and Daina Variakojis and David T. Rowe and Haroutune K. Armenian}, journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology}, year={1999}, volume={8 11}, pages={979-84} }